Skip to main content
Erschienen in: Inflammation 6/2011

01.12.2011

Dynamics of Inflammatory Markers in Post-Acute Stroke Patients Undergoing Rehabilitation

verfasst von: Bogdan Nicolae Manolescu, Mihai Berteanu, Luminița Dumitru, Horațiu Dinu, Alina Iliescu, Ileana Cornelia Fărcășanu, Eliza Oprea, Suzana Vlădoiu, Oana Popa, Olga Ianăș

Erschienen in: Inflammation | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Stroke is a pathological condition associated with an enhanced inflammatory response that has a multifactorial etiology. We evaluated the dynamic of plasma concentrations of IL-1α, IL-6, IL-8, TNF-α, soluble form of intercellular adhesion molecule 1, and lipoprotein (a) [Lp(a)] during the rehabilitation of post-acute stroke patients (n = 20), in parallel with control subjects (n = 24). Stroke patients had significantly increased concentrations of IL-6, TNF-α, and Lp(a) when compared to healthy controls. It was found that the changes in the IL-6, IL-8, and TNF-α concentrations associated with the pathological condition were statistically significant (χ 2 = 4.81, p = 0.028, χ 2 = 10.40, p = 0.005 and χ 2 = 6.73, p = 0.034, respectively). The decrease of Lp(a) during the rehabilitation had statistical significance (p = 0.043), while the decrease of IL-1α had marginal significance (p = 0.071). IL-1α, TNF-α, and Lp(a) concentrations were significantly negatively correlated with the Barthel index values, suggesting that the decrease of these inflammatory markers was beneficial for patients’ recovery.
Literatur
1.
Zurück zum Zitat De Simoni, M.G., P. Milia, M. Barba, A. De Luigi, L. Parnetti, and V. Gallai. 2002. The inflammatory response in cerebral ischemia: Focus on cytokines in stroke patients. Clinical and Experimental Hypertension 24: 535–542.PubMedCrossRef De Simoni, M.G., P. Milia, M. Barba, A. De Luigi, L. Parnetti, and V. Gallai. 2002. The inflammatory response in cerebral ischemia: Focus on cytokines in stroke patients. Clinical and Experimental Hypertension 24: 535–542.PubMedCrossRef
2.
Zurück zum Zitat Doyle, K.P., R.P. Simon, and M.P. Stenzel-Poore. 2008. Mechanisms of ischemic brain damage. Neuropharmacology 55: 310–318.PubMedCrossRef Doyle, K.P., R.P. Simon, and M.P. Stenzel-Poore. 2008. Mechanisms of ischemic brain damage. Neuropharmacology 55: 310–318.PubMedCrossRef
3.
Zurück zum Zitat Wong, C.H., and P.J. Crack. 2008. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Current Medicinal Chemistry 15: 1–14.PubMedCrossRef Wong, C.H., and P.J. Crack. 2008. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Current Medicinal Chemistry 15: 1–14.PubMedCrossRef
4.
Zurück zum Zitat Song, Y.S., M.S. Kim, H.A. Kim, B.I. Jung, J. Yang, P. Narasimhan, G.S. Kim, J.E. Jung, E.H. Park, and P.H. Chan. 2010. Oxidative stress increases phosphorylation of IkappaB kinase-alpha by enhancing NF-kappaB-inducing kinase after transient focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. doi:10.1038/jcbfm.2010.6. Song, Y.S., M.S. Kim, H.A. Kim, B.I. Jung, J. Yang, P. Narasimhan, G.S. Kim, J.E. Jung, E.H. Park, and P.H. Chan. 2010. Oxidative stress increases phosphorylation of IkappaB kinase-alpha by enhancing NF-kappaB-inducing kinase after transient focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. doi:10.​1038/​jcbfm.​2010.​6.
5.
Zurück zum Zitat Liu, K.J., and G.A. Rosenberg. 2005. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radical Biology & Medicine 39: 71–80.CrossRef Liu, K.J., and G.A. Rosenberg. 2005. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radical Biology & Medicine 39: 71–80.CrossRef
6.
Zurück zum Zitat Jin, R., G. Yang, and G. Li. 2010. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. Journal of Leukocyte Biology 87: 779–789.PubMedCrossRef Jin, R., G. Yang, and G. Li. 2010. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. Journal of Leukocyte Biology 87: 779–789.PubMedCrossRef
7.
Zurück zum Zitat Perera, M.N., H.K. Ma, S. Arakawa, D.W. Howells, R. Markus, C.C. Rowe, and G.A. Donnan. 2006. Inflammation following stroke. Journal of Clinical Neuroscience 13: 1–8.CrossRef Perera, M.N., H.K. Ma, S. Arakawa, D.W. Howells, R. Markus, C.C. Rowe, and G.A. Donnan. 2006. Inflammation following stroke. Journal of Clinical Neuroscience 13: 1–8.CrossRef
8.
Zurück zum Zitat Jones, G.T., M. Deng, G.D. Hammond-Tooke, S.P.A. McCormick, and A.M. van Rij. 2009. Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke. Clinical Chemistry 55: 1888–1890.PubMedCrossRef Jones, G.T., M. Deng, G.D. Hammond-Tooke, S.P.A. McCormick, and A.M. van Rij. 2009. Increased plasma lipoprotein(a) found in large-artery atherosclerotic, but not small-artery occlusive, stroke. Clinical Chemistry 55: 1888–1890.PubMedCrossRef
9.
Zurück zum Zitat Mahoney, F.I., and D.W. Barthel. 1965. Functional evaluation: The Barthel index. Maryland State Medical Journal 24: 61–69. Mahoney, F.I., and D.W. Barthel. 1965. Functional evaluation: The Barthel index. Maryland State Medical Journal 24: 61–69.
10.
Zurück zum Zitat Adams, H.P., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, and E.E. Marsh. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24: 35–41.PubMedCrossRef Adams, H.P., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L. Gordon, and E.E. Marsh. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24: 35–41.PubMedCrossRef
11.
Zurück zum Zitat Slemmer, J.E., J.J. Shacka, M.I. Sweeney, and J.T. Weber. 2008. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry 15: 404–414.PubMedCrossRef Slemmer, J.E., J.J. Shacka, M.I. Sweeney, and J.T. Weber. 2008. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry 15: 404–414.PubMedCrossRef
12.
Zurück zum Zitat Tarkowski, E., L. Rosengren, C. Blomstrand, C. Wikkelsö, C. Jensen, S. Ekholm, and A. Tarkowski. 1995. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26: 1393–1398.PubMedCrossRef Tarkowski, E., L. Rosengren, C. Blomstrand, C. Wikkelsö, C. Jensen, S. Ekholm, and A. Tarkowski. 1995. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26: 1393–1398.PubMedCrossRef
13.
Zurück zum Zitat Lakhan, S.E., A. Kirchgessner, and M. Hofer. 2009. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. Journal of Translational Medicine 7: 97–106.PubMedCrossRef Lakhan, S.E., A. Kirchgessner, and M. Hofer. 2009. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. Journal of Translational Medicine 7: 97–106.PubMedCrossRef
14.
Zurück zum Zitat Ferrarese, C., P. Mascarucci, C. Zoia, R. Cavarretta, M. Frigo, B. Begni, F. Sarinella, L. Frattola, and M.G. de Simoni. 1999. Increased cytokine release from peripheral blood cells after acute stroke. Journal of Cerebral Blood Flow and Metabolism 19: 1004–1009.PubMed Ferrarese, C., P. Mascarucci, C. Zoia, R. Cavarretta, M. Frigo, B. Begni, F. Sarinella, L. Frattola, and M.G. de Simoni. 1999. Increased cytokine release from peripheral blood cells after acute stroke. Journal of Cerebral Blood Flow and Metabolism 19: 1004–1009.PubMed
15.
Zurück zum Zitat Elkind, M.S., J. Cheng, T. Rundek, B. Boden-Albala, and R.L. Sacco. 2004. Leukocyte count predicts outcome after ischemic stroke: The northern Manhattan stroke study. Journal of Stroke and Cerebrovascular Diseases 13: 220–227.PubMedCrossRef Elkind, M.S., J. Cheng, T. Rundek, B. Boden-Albala, and R.L. Sacco. 2004. Leukocyte count predicts outcome after ischemic stroke: The northern Manhattan stroke study. Journal of Stroke and Cerebrovascular Diseases 13: 220–227.PubMedCrossRef
16.
Zurück zum Zitat Wu, D., and S.N. Meydani. 2008. Age-associated changes in immune and inflammatory responses: Impact of vitamin E intervention. Journal of Leukocyte Biology 84: 900–914.PubMedCrossRef Wu, D., and S.N. Meydani. 2008. Age-associated changes in immune and inflammatory responses: Impact of vitamin E intervention. Journal of Leukocyte Biology 84: 900–914.PubMedCrossRef
17.
Zurück zum Zitat Kostulas, N., S.H. Pelidou, P. Kivisäkk, V. Kostulas, and H. Link. 1999. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30: 2174–2179.PubMedCrossRef Kostulas, N., S.H. Pelidou, P. Kivisäkk, V. Kostulas, and H. Link. 1999. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30: 2174–2179.PubMedCrossRef
18.
Zurück zum Zitat Kettritz, R., M.L. Gaido, H. Haller, F.C. Luft, C.J. Jennette, and R.J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated apoptosis of human neutrophils. Kidney International 53: 84–91.PubMedCrossRef Kettritz, R., M.L. Gaido, H. Haller, F.C. Luft, C.J. Jennette, and R.J. Falk. 1998. Interleukin-8 delays spontaneous and tumor necrosis factor-α-mediated apoptosis of human neutrophils. Kidney International 53: 84–91.PubMedCrossRef
19.
Zurück zum Zitat Acalovschi, D., T. Wiest, M. Hartmann, M. Farahmi, U. Mansmann, G.U. Auffarth, A.J. Grau, F.R. Green, C. Grond-Ginsbach, and M. Schwaninger. 2003. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864–1869.PubMedCrossRef Acalovschi, D., T. Wiest, M. Hartmann, M. Farahmi, U. Mansmann, G.U. Auffarth, A.J. Grau, F.R. Green, C. Grond-Ginsbach, and M. Schwaninger. 2003. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864–1869.PubMedCrossRef
20.
Zurück zum Zitat Tarkowski, E., L. Rosengren, C. Blomstrand, C. Jensen, S. Ekholm, and A. Tarkowski. 1999. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 30: 321–327.PubMedCrossRef Tarkowski, E., L. Rosengren, C. Blomstrand, C. Jensen, S. Ekholm, and A. Tarkowski. 1999. Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke 30: 321–327.PubMedCrossRef
21.
Zurück zum Zitat Vila, N., J. Castillo, A. Davalos, and A. Chamorro. 2003. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325–2329.CrossRef Vila, N., J. Castillo, A. Davalos, and A. Chamorro. 2003. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325–2329.CrossRef
22.
Zurück zum Zitat Nakase, T., T. Yamazaki, N. Ogura, A. Suzuki, and K. Nagata. 2008. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. Journal of the Neurological Sciences 271: 104–109.PubMedCrossRef Nakase, T., T. Yamazaki, N. Ogura, A. Suzuki, and K. Nagata. 2008. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. Journal of the Neurological Sciences 271: 104–109.PubMedCrossRef
23.
Zurück zum Zitat Dziedzic, T., A. Slowik, J. Pera, and A. Szczudlik. 2005. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovascular Diseases 20: 299–303.PubMedCrossRef Dziedzic, T., A. Slowik, J. Pera, and A. Szczudlik. 2005. Interleukin 1 beta polymorphism (-511) and risk of stroke due to small vessel disease. Cerebrovascular Diseases 20: 299–303.PubMedCrossRef
24.
Zurück zum Zitat Tong, Y., Y. Geng, J. Xu, Z. Wang, Y. Zhang, L. Lin, R. Zhang, P. Deng, Y. Li, W. Hou, Y. Chai, K.A. Mason, Z. Lu, and J. Cheng. 2010. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies. Clinica Chimica Acta. doi:10.1016/j.cca.2010.05.007. Tong, Y., Y. Geng, J. Xu, Z. Wang, Y. Zhang, L. Lin, R. Zhang, P. Deng, Y. Li, W. Hou, Y. Chai, K.A. Mason, Z. Lu, and J. Cheng. 2010. The role of functional polymorphisms of the TNF-alpha gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case-control studies. Clinica Chimica Acta. doi:10.​1016/​j.​cca.​2010.​05.​007.
25.
Zurück zum Zitat Al-Bahrani, A., S. Taha, H. Shaath, and M. Bakhiet. 2007. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Current Neurovascular Research 4: 31–37.PubMedCrossRef Al-Bahrani, A., S. Taha, H. Shaath, and M. Bakhiet. 2007. TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Current Neurovascular Research 4: 31–37.PubMedCrossRef
26.
Zurück zum Zitat Woodfin, A., M.B. Voisin, and S. Nourshargh. 2010. Recent developments and complexities in neutrophil transmigration. Current Opinion in Hematology 17: 9–17.PubMedCrossRef Woodfin, A., M.B. Voisin, and S. Nourshargh. 2010. Recent developments and complexities in neutrophil transmigration. Current Opinion in Hematology 17: 9–17.PubMedCrossRef
27.
Zurück zum Zitat The Emerging Risk Factors Collaboration. 2009. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Journal of the American Medical Association 302: 412–423.CrossRef The Emerging Risk Factors Collaboration. 2009. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Journal of the American Medical Association 302: 412–423.CrossRef
28.
Zurück zum Zitat Dechanet, J., C. Grosset, J.L. Taupin, P. Merville, J. Banchereau, J. Ripoche, and J.F. Moreau. 1997. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. Journal of Immunology 159: 5640–5647. Dechanet, J., C. Grosset, J.L. Taupin, P. Merville, J. Banchereau, J. Ripoche, and J.F. Moreau. 1997. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. Journal of Immunology 159: 5640–5647.
29.
Zurück zum Zitat Poon, M., X. Zhang, K.G. Dunsky, M.B. Taubman, and P.C. Harpel. 1997. Apolipoprotein(a) induces chemotactic activity in human vascular endothelial cells. Circulation 96: 2514–2519.PubMed Poon, M., X. Zhang, K.G. Dunsky, M.B. Taubman, and P.C. Harpel. 1997. Apolipoprotein(a) induces chemotactic activity in human vascular endothelial cells. Circulation 96: 2514–2519.PubMed
30.
Zurück zum Zitat Galvano, F., M. Malaguarnera, M. Vacante, M. Motta, C. Russo, G. Malaguarnera, N. D’Orazio, and L. Malaguarnera. 2010. The physiopathology of lipoprotein (a). Frontiers in Bioscience 2: 866–875.CrossRef Galvano, F., M. Malaguarnera, M. Vacante, M. Motta, C. Russo, G. Malaguarnera, N. D’Orazio, and L. Malaguarnera. 2010. The physiopathology of lipoprotein (a). Frontiers in Bioscience 2: 866–875.CrossRef
Metadaten
Titel
Dynamics of Inflammatory Markers in Post-Acute Stroke Patients Undergoing Rehabilitation
verfasst von
Bogdan Nicolae Manolescu
Mihai Berteanu
Luminița Dumitru
Horațiu Dinu
Alina Iliescu
Ileana Cornelia Fărcășanu
Eliza Oprea
Suzana Vlădoiu
Oana Popa
Olga Ianăș
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 6/2011
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-010-9262-8

Weitere Artikel der Ausgabe 6/2011

Inflammation 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.